Mark Vignola, Ph.D.

Director, Investor Relations, Intercept Pharmaceuticals

Photograph of Mark Vignola, Ph.D. Mark J. Vignola, Ph.D. has served as Director of Investor Relations at Intercept since June 2015. Dr. Vignola joined intercept from Needham and Co, where he was a research analyst covering the biotechnology sector. He started his career on Wall Street at Lehman Brothers. Dr. Vignola holds a Bachelor of Science degree in biology from Boston College and a Ph.D. in Molecular Genetics and Microbiology from Duke University.